← Back to Search
Behavioral Intervention
Cognitive Strategies for Stroke (CHAMPS-TR Trial)
Albuquerque, NM
N/A
Recruiting
Research Sponsored by University of New Mexico
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
7. greater than 40 years of age
1. primary diagnosis of acute ischemic stroke
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, up to 7 weeks, and up to 24 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to test a program that helps people who have had a stroke and their family members reduce the risk of having another stroke and experiencing further cognitive decline. The program involves cognitive strategy training and health
See full description
Who is the study for?
This trial is for adults over 40 who've had an ischemic stroke and show cognitive impairment but don't have severe aphasia, pre-stroke dementia, major anxiety or depression, or recent substance misuse. They need a family member who qualifies to participate and must be able to undergo MRI and RS-tDCS treatments safely.Check my eligibility
What is being tested?
The study tests a virtual program called CHAMPS-TR that combines cognitive strategy training with health coaching. It aims to reduce vascular risk and improve brain health in people who've had a stroke as well as their biological family members at risk.See study design
What are the potential side effects?
Since the intervention involves non-invasive brain stimulation (RS-tDCS) and cognitive training, side effects may include mild discomfort or skin irritation at the stimulation site, headache, fatigue, or temporary changes in mood.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am over 40 years old.
show original
Select...
I have been diagnosed with an acute ischemic stroke.
show original
Select...
I am at least 18 years old.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, up to 7 weeks, and up to 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, up to 7 weeks, and up to 24 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
American Heart Association Life's Essential 8 Metrics
Cardiovascular risk factors, Aging, and Incidence of Dementia (CAIDE)
Secondary study objectives
Mark VCID2 Clinical Cognitive Assessment Battery
Multiple Errands Test Home Version
Number Span Test Forward and Backward
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: CHAMPS-TRExperimental Treatment1 Intervention
Persons with stroke and a targeted biological family member will receive the CHAMPS intervention including vascular risk reduction coaching and cognitive strategy training.
Group II: CHAMPS TR plus remotely supervised transcranial direct current stimulation (RS-tDCS)Experimental Treatment1 Intervention
Persons with stroke and a targeted biological family member will receive the CHAMPS intervention including vascular risk reduction coaching and cognitive strategy training. Persons with stroke will also receive RS-tDCS.
Find a Location
Closest Location:University of New Mexico Health Sciences Center· Albuquerque, NM
Who is running the clinical trial?
University of New MexicoLead Sponsor
390 Previous Clinical Trials
3,526,179 Total Patients Enrolled
2 Trials studying Ischemic Stroke
4,606 Patients Enrolled for Ischemic Stroke